Year |
Citation |
Score |
2022 |
Czapiewski R, Batrakou DG, de Las Heras JI, Carter RN, Sivakumar A, Sliwinska M, Dixon CR, Webb S, Lattanzi G, Morton NM, Schirmer EC. Genomic loci mispositioning in Tmem120a knockout mice yields latent lipodystrophy. Nature Communications. 13: 321. PMID 35027552 DOI: 10.1038/s41467-021-27869-2 |
0.752 |
|
2017 |
de Las Heras JI, Zuleger N, Batrakou DG, Czapiewski R, Kerr AR, Schirmer EC. Tissue-specific NETs alter genome organization and regulation even in a heterologous system. Nucleus (Austin, Tex.). 1-17. PMID 28045568 DOI: 10.1080/19491034.2016.1261230 |
0.794 |
|
2015 |
Batrakou DG, de Las Heras JI, Czapiewski R, Mouras R, Schirmer EC. TMEM120A and B: Nuclear Envelope Transmembrane Proteins Important for Adipocyte Differentiation. Plos One. 10: e0127712. PMID 26024229 DOI: 10.1371/Journal.Pone.0127712 |
0.828 |
|
2013 |
de Las Heras JI, Meinke P, Batrakou DG, Srsen V, Zuleger N, Kerr AR, Schirmer EC. Tissue specificity in the nuclear envelope supports its functional complexity. Nucleus (Austin, Tex.). 4: 460-77. PMID 24213376 DOI: 10.4161/Nucl.26872 |
0.824 |
|
2013 |
Zuleger N, Boyle S, Kelly DA, de las Heras JI, Lazou V, Korfali N, Batrakou DG, Randles KN, Morris GE, Harrison DJ, Bickmore WA, Schirmer EC. Specific nuclear envelope transmembrane proteins can promote the location of chromosomes to and from the nuclear periphery. Genome Biology. 14: R14. PMID 23414781 DOI: 10.1186/Gb-2013-14-2-R14 |
0.794 |
|
2013 |
de Las Heras JI, Batrakou DG, Schirmer EC. Cancer biology and the nuclear envelope: a convoluted relationship. Seminars in Cancer Biology. 23: 125-37. PMID 22311402 DOI: 10.1016/j.semcancer.2012.01.008 |
0.711 |
|
2012 |
Korfali N, Wilkie GS, Swanson SK, Srsen V, de Las Heras J, Batrakou DG, Malik P, Zuleger N, Kerr AR, Florens L, Schirmer EC. The nuclear envelope proteome differs notably between tissues. Nucleus (Austin, Tex.). 3: 552-64. PMID 22990521 DOI: 10.4161/Nucl.22257 |
0.765 |
|
2011 |
Korfali N, Srsen V, Waterfall M, Batrakou DG, Pekovic V, Hutchison CJ, Schirmer EC. A flow cytometry-based screen of nuclear envelope transmembrane proteins identifies NET4/Tmem53 as involved in stress-dependent cell cycle withdrawal. Plos One. 6: e18762. PMID 21533191 DOI: 10.1371/Journal.Pone.0018762 |
0.796 |
|
2011 |
Wilkie GS, Korfali N, Swanson SK, Malik P, Srsen V, Batrakou DG, de las Heras J, Zuleger N, Kerr AR, Florens L, Schirmer EC. Several novel nuclear envelope transmembrane proteins identified in skeletal muscle have cytoskeletal associations. Molecular & Cellular Proteomics : McP. 10: M110.003129. PMID 20876400 DOI: 10.1074/Mcp.M110.003129 |
0.76 |
|
2010 |
Korfali N, Wilkie GS, Swanson SK, Srsen V, Batrakou DG, Fairley EA, Malik P, Zuleger N, Goncharevich A, de Las Heras J, Kelly DA, Kerr AR, Florens L, Schirmer EC. The leukocyte nuclear envelope proteome varies with cell activation and contains novel transmembrane proteins that affect genome architecture. Molecular & Cellular Proteomics : McP. 9: 2571-85. PMID 20693407 DOI: 10.1074/Mcp.M110.002915 |
0.725 |
|
2010 |
Malik P, Korfali N, Srsen V, Lazou V, Batrakou DG, Zuleger N, Kavanagh DM, Wilkie GS, Goldberg MW, Schirmer EC. Cell-specific and lamin-dependent targeting of novel transmembrane proteins in the nuclear envelope. Cellular and Molecular Life Sciences : Cmls. 67: 1353-69. PMID 20091084 DOI: 10.1007/S00018-010-0257-2 |
0.758 |
|
2009 |
Batrakou DG, Kerr AR, Schirmer EC. Comparative proteomic analyses of the nuclear envelope and pore complex suggests a wide range of heretofore unexpected functions. Journal of Proteomics. 72: 56-70. PMID 18852071 DOI: 10.1016/j.jprot.2008.09.004 |
0.701 |
|
Low-probability matches (unlikely to be authored by this person) |
2020 |
Batrakou DG, Müller CA, Wilson RHC, Nieduszynski CA. DNA copy-number measurement of genome replication dynamics by high-throughput sequencing: the sort-seq, sync-seq and MFA-seq family. Nature Protocols. PMID 32051615 DOI: 10.1038/s41596-019-0287-7 |
0.239 |
|
2018 |
Batrakou DG, Heron ED, Nieduszynski CA. Rapid high-resolution measurement of DNA replication timing by droplet digital PCR. Nucleic Acids Research. 46: e112. PMID 29986073 DOI: 10.1093/nar/gky590 |
0.175 |
|
2022 |
Blumenschein GR, Devarakonda S, Johnson M, Moreno V, Gainor J, Edelman MJ, Heymach JV, Govindan R, Bachier C, Doger de Spéville B, Frigault MJ, Olszanski AJ, Lam VK, Hyland N, Navenot JM, ... ... Batrakou D, et al. Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10 advanced non-small cell lung cancer. Journal For Immunotherapy of Cancer. 10. PMID 35086946 DOI: 10.1136/jitc-2021-003581 |
0.114 |
|
2022 |
Hong DS, Butler MO, Pachynski RK, Sullivan R, Kebriaei P, Boross-Harmer S, Ghobadi A, Frigault MJ, Dumbrava EE, Sauer A, Brophy F, Navenot JM, Fayngerts S, Wolchinsky Z, Broad R, ... Batrakou DG, et al. Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors. Frontiers in Oncology. 12: 818679. PMID 35372008 DOI: 10.3389/fonc.2022.818679 |
0.104 |
|
2023 |
Hong DS, Van Tine BA, Biswas S, McAlpine C, Johnson ML, Olszanski AJ, Clarke JM, Araujo D, Blumenschein GR, Kebriaei P, Lin Q, Tipping AJ, Sanderson JP, Wang R, Trivedi T, ... ... Batrakou DG, et al. Autologous T cell therapy for MAGE-A4 solid cancers in HLA-A*02 patients: a phase 1 trial. Nature Medicine. PMID 36624315 DOI: 10.1038/s41591-022-02128-z |
0.096 |
|
Hide low-probability matches. |